Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9
eBook - ePub

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9

About this book

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. Volume 9 features reviews on these topics: · Dietary Strategy for Cancer Therapy - Amino Acid Restrictions and Beyond · The Revolutionary Potential of Noble Metal Nanoparticles as Anti-Cancer Agents: State-of-the-Art Applications and Future Perspectives · Algal Polysaccharides as Promising Anticancer Agents · Cardiotoxicity Caused by Doxorubicin and Trastuzumab: Current Understanding for Future Preventive Strategies · Emodin: Anticancer Agent Readership Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 9 by Atta-ur-Rahman in PDF and/or ePUB format, as well as other popular books in Physical Sciences & Clinical Chemistry. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Bentham Science Publishers
Year
2024
eBook ISBN
9789815223910
Edition
0
Topic
Physical Sciences
Subtopic
Clinical Chemistry

Table of contents

  1. Welcome
  2. Table of Content
  3. Title
  4. BENTHAM SCIENCE PUBLISHERS LTD.
  5. PREFACE
  6. List of Contributors
  7. Dietary Strategy for Cancer Therapy - Amino Acid Restrictions and beyond
  8. The Revolutionary Potential of Noble Metal Nanoparticles as Anti-Cancer Agents: State-Of- The-Art Applications and Future Perspectives
  9. Algal Polysaccharides as Promising Anticancer Agents
  10. Cardiotoxicity Caused by Doxorubicin and Trastuzumab: Current Understanding for Future Preventive Strategies
  11. Emodin: Anticancer Agent